Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Editas Medicine Inc EDIT

Healthcare Biotechnology
Editas Medicine, Inc. is a clinical-stage genome editing company. The Company is focused on developing potentially transformative genomic medicines to treat a broad range of serious diseases. It has developed a proprietary gene editing platform based on CRISPR technology. CRISPR uses a protein- ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:EDIT)

Editas Medicine to Participate in Upcoming Investor Conferences

GlobeNewswire November 6, 2024

Editas Medicine Announces Third Quarter 2024 Results and Business Updates

GlobeNewswire November 4, 2024

Editas Medicine Announces Progress Towards 2024 Goals, Including Achievement of In Vivo Preclinical Proof of Concept and Strategic Update

GlobeNewswire October 22, 2024

Editas Medicine and Genevant Sciences to Collaborate to Develop Novel mRNA-LNP Gene Editing Therapeutics

GlobeNewswire October 21, 2024

Editas Medicine to Host Strategic Update Webinar to Detail Progress Towards 2024 Goals, Including Achievement of Establishing In Vivo Preclinical Proof of Concept

GlobeNewswire October 18, 2024

Editas Medicine Announces $50+ Million Monetization Financing with DRI Healthcare Trust

GlobeNewswire October 3, 2024

Editas Medicine to Participate in Upcoming Investor Conferences

GlobeNewswire August 28, 2024

Editas Medicine Announces Second Quarter 2024 Results and Business Updates

GlobeNewswire August 7, 2024

Editas Medicine Announces Second Quarter 2024 Results Conference Call and Corporate Update

GlobeNewswire July 31, 2024
View More News ››

Opinion & Analysis (NDAQ:EDIT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:EDIT)

Editas Medicine and Genevant Sciences to Collaborate to Deve

Breaking News: $EDIT Editas Medicine and Genevant Sciences to Collaborate to Develop Novel mRNA-LNP Gene Editing TherapeuticsCAMBRIDGE...
whytestocks - October 21, 2024

RE:Ruby study expected to be completed Aug 2025

https://www.globenewswire.com/news-release/2020/12/05/2140152/0/en/CRISPR-Therapeutics-and-Vertex-Present-New-Data-for-Investigational...
Napcoo - May 21, 2024

Ruby study expected to be completed Aug 2025

 https://www.clinicaltrials.gov/study/NCT04853576
Napcoo - May 16, 2024

RE:Genome Therapy New Biotech Darling?

http://www.innovationnewsnetwork.com/crispr-technology-achieves-dna-repair-in-space-for-the-first-time/14184/
0checker - August 19, 2021

RE:Genome Therapy New Biotech Darling?

  Hi there, in the recent Jeff Brown pitch for his "exponential tech investor" he talks about a small cap biotech...
chiefmissile - December 27, 2020

Genome Therapy New Biotech Darling?

Just finished getting pitched Jeff Brown's newsletter for a small cap gene therapy company. I'm not sure which is his pick, but...
bcwildthing - November 3, 2020
View more Bullboard ››

Nicola Mining Inc

Nicola Mining Inc

Nicola Mining Inc. is a Canada-based junior mining company. The Company maintains a 100% owned mill and tailings facility ...
View More »